Alembic Pharmaceuticals Limited has informed the Exchange about General Updates - Incorporation of Subsidiary
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has incorporated a new wholly-owned subsidiary named Alembic Pharmaceuticals (Thailand) Co., Ltd. in Thailand. The subsidiary has a share capital of Baht 3,000,000 (Three Million Baht) divided into 3,00,000 shares of Baht 10 each, and Alembic holds 99.99% stake in it. The new entity has not yet commenced business operations, so its turnover is currently nil. The purpose of setting up this subsidiary is to explore new business opportunities in Thailand and to promote, sell and distribute Alembic's pharmaceutical products in that geography. No governmental or regulatory approvals were required, and the consideration was an investment in the share capital of the new company.
This is a small, strategic step towards expanding Alembic's international footprint into the Thai pharmaceutical market. The financial outlay is modest (around Baht 3 million), and since operations haven't begun yet, there is no immediate impact on earnings. Investors may view this as a mildly positive long-term move to grow the company's distribution reach overseas.